Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone"
Código 293721 (Harmonized System 2012 by 6 digits)
2022: US$1.32k, International Sales
2023: US$2.6M, International Purchases
Código 293721 (Harmonized System 2012 by 6 digits)
2022: US$1.32k, International Sales
2023: US$2.6M, International Purchases
The states with the most international purchases in 2023 were Jalisco (US$1.66M), Estado de México (US$589k), and Ciudad de México (US$344k).
The main commercial origins of Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone" in 2023 were China (US$1.92M), Spain (US$574k), France (US$98.3k), Malaysia (US$1.1k), and Italy (US$269).
In the global context, the main exporting countries of Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone" in 2022 were China (US$171M), Italy (US$30.1M), and France (US$24M). In the same year, the main importing countries of Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone" were India (US$38.8M), Brazil (US$30M), and United States (US$25.9M).
The visualizations show the net balance of Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone" at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
November, 2024: US$186k, International Purchases
In November 2024, international sales of Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone" were US$0, while international purchases reached US$186k. The above results in a trade balance of -US$186k.
Jalisco: US$1.66M, State with the Most International Purchases (2023)
China: US$1.92M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone" were Jalisco (US$1.66M), Estado de México (US$589k), and Ciudad de México (US$344k).
The countries with the most international sales to Mexico in 2023 were China (US$1.92M), Spain (US$574k), France (US$98.3k), Malaysia (US$1.1k), and Italy (US$269).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone" and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone". On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone". In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone" were China (US$171M), Italy (US$30.1M), and France (US$24M). In the same year, the main importing countries for Cortisone, Hydrocortisone, Prednisone "Dehydrocortisone" and Prednisolone "Dehydrocortisone" were India (US$38.8M), Brazil (US$30M), and United States (US$25.9M).